DK1658277T3 - Succinat- og malonatsalt af trans-4-(1r,3s)-6-chlor-3-phenylindan-1-yl)-1,2,2-trimethylpiperazin og anvendelse som medikament - Google Patents
Succinat- og malonatsalt af trans-4-(1r,3s)-6-chlor-3-phenylindan-1-yl)-1,2,2-trimethylpiperazin og anvendelse som medikamentInfo
- Publication number
- DK1658277T3 DK1658277T3 DK04762772.4T DK04762772T DK1658277T3 DK 1658277 T3 DK1658277 T3 DK 1658277T3 DK 04762772 T DK04762772 T DK 04762772T DK 1658277 T3 DK1658277 T3 DK 1658277T3
- Authority
- DK
- Denmark
- Prior art keywords
- phenylindan
- trimethylpiperazine
- chlor
- succinate
- trans
- Prior art date
Links
- 150000002690 malonic acid derivatives Chemical class 0.000 title 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C17/00—Preparation of halogenated hydrocarbons
- C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
- C07C17/16—Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C25/00—Compounds containing at least one halogen atom bound to a six-membered aromatic ring
- C07C25/18—Polycyclic aromatic halogenated hydrocarbons
- C07C25/22—Polycyclic aromatic halogenated hydrocarbons with condensed rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
- C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
- C07C29/143—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
- C07C35/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings
- C07C35/32—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings the condensed ring system being a (4.3.0) system, e.g. indenols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
- C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49605803P | 2003-08-18 | 2003-08-18 | |
| DKPA200301180 | 2003-08-18 | ||
| DKPA200301305 | 2003-09-11 | ||
| US52024603P | 2003-11-14 | 2003-11-14 | |
| PCT/DK2004/000545 WO2005016900A1 (en) | 2003-08-18 | 2004-08-18 | Succinate and malonate salt of trans-4-(ir,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1658277T3 true DK1658277T3 (da) | 2012-06-18 |
Family
ID=58707237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04762772.4T DK1658277T3 (da) | 2003-08-18 | 2004-08-18 | Succinat- og malonatsalt af trans-4-(1r,3s)-6-chlor-3-phenylindan-1-yl)-1,2,2-trimethylpiperazin og anvendelse som medikament |
Country Status (15)
| Country | Link |
|---|---|
| KR (2) | KR101227789B1 (de) |
| CN (1) | CN101935305B (de) |
| AR (2) | AR045279A1 (de) |
| AT (1) | ATE552247T1 (de) |
| DK (1) | DK1658277T3 (de) |
| EA (2) | EA014641B1 (de) |
| ES (1) | ES2383369T3 (de) |
| IS (1) | IS8264A (de) |
| ME (1) | MEP2408A (de) |
| MY (2) | MY149089A (de) |
| PT (1) | PT1658277E (de) |
| RS (3) | RS20060121A (de) |
| SG (2) | SG148183A1 (de) |
| SI (1) | SI1658277T1 (de) |
| TW (2) | TWI403505B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI453198B (zh) * | 2005-02-16 | 2014-09-21 | Lundbeck & Co As H | 製造反式-1-((1r,3s)-6-氯基-3-苯基茚滿-1-基) -3 , 3 -二甲基六氫吡與其鹽類之方法及製造4-((1r , 3s)-6 -氯基-3-苯基茚滿-1-基 )-1,2,2-三甲基六氫吡與其鹽類之方法 |
| DK2720989T3 (en) | 2011-06-20 | 2016-11-28 | H Lundbeck As | Deuterated 1-piperazino-3-phenyl-indanes used to treat schizophrenia |
| MX2021012248A (es) | 2019-04-11 | 2022-03-11 | Mei Pharma Inc | Polimorfos de voruciclib y metodos de elaboracion y uso de los mismos. |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE50867B1 (en) * | 1980-02-29 | 1986-08-06 | Kefalas As | Indane derivatives |
| DK55192D0 (da) * | 1992-04-28 | 1992-04-28 | Lundbeck & Co As H | 1-piperazino-1,2-dihydroindenderivater |
-
2004
- 2004-08-18 ME MEP-24/08A patent/MEP2408A/xx unknown
- 2004-08-18 DK DK04762772.4T patent/DK1658277T3/da active
- 2004-08-18 KR KR1020067003177A patent/KR101227789B1/ko not_active Expired - Fee Related
- 2004-08-18 EA EA200600441A patent/EA014641B1/ru not_active IP Right Cessation
- 2004-08-18 MY MYPI20043353A patent/MY149089A/en unknown
- 2004-08-18 SI SI200431885T patent/SI1658277T1/sl unknown
- 2004-08-18 KR KR1020067003357A patent/KR20060066104A/ko not_active Withdrawn
- 2004-08-18 ES ES04762772T patent/ES2383369T3/es not_active Expired - Lifetime
- 2004-08-18 EA EA200600443A patent/EA200600443A1/ru unknown
- 2004-08-18 SG SG200808521-9A patent/SG148183A1/en unknown
- 2004-08-18 RS YUP-2006/0121A patent/RS20060121A/sr unknown
- 2004-08-18 AT AT04762772T patent/ATE552247T1/de active
- 2004-08-18 AR ARP040102967A patent/AR045279A1/es not_active Application Discontinuation
- 2004-08-18 CN CN2010101632528A patent/CN101935305B/zh not_active Expired - Fee Related
- 2004-08-18 RS YUP-2006/0083A patent/RS20060083A/sr unknown
- 2004-08-18 TW TW099140932A patent/TWI403505B/zh not_active IP Right Cessation
- 2004-08-18 MY MYPI20082882A patent/MY154535A/en unknown
- 2004-08-18 RS RS20060121A patent/RS53369B/sr unknown
- 2004-08-18 AR ARP040102966A patent/AR045278A1/es not_active Application Discontinuation
- 2004-08-18 TW TW093124784A patent/TWI388550B/zh not_active IP Right Cessation
- 2004-08-18 PT PT04762772T patent/PT1658277E/pt unknown
- 2004-08-18 SG SG200805893-5A patent/SG145723A1/en unknown
-
2006
- 2006-01-26 IS IS8264A patent/IS8264A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101935305A (zh) | 2011-01-05 |
| AR045278A1 (es) | 2005-10-19 |
| KR101227789B1 (ko) | 2013-01-30 |
| IS8264A (is) | 2006-01-26 |
| MEP2408A (xx) | 2010-02-10 |
| ATE552247T1 (de) | 2012-04-15 |
| SG148183A1 (en) | 2008-12-31 |
| RS20060121A (sr) | 2008-09-29 |
| RS20060083A (sr) | 2008-08-07 |
| HK1096089A1 (en) | 2007-05-25 |
| EA014641B1 (ru) | 2010-12-30 |
| SI1658277T1 (sl) | 2012-10-30 |
| SG145723A1 (en) | 2008-09-29 |
| TWI403505B (zh) | 2013-08-01 |
| TW200519098A (en) | 2005-06-16 |
| TWI388550B (zh) | 2013-03-11 |
| EA200600441A1 (ru) | 2006-08-25 |
| AR045279A1 (es) | 2005-10-19 |
| RS53369B (sr) | 2014-10-31 |
| MY149089A (en) | 2013-07-15 |
| TW201111351A (en) | 2011-04-01 |
| HK1152699A1 (en) | 2012-03-09 |
| PT1658277E (pt) | 2012-05-25 |
| EA200600443A1 (ru) | 2006-08-25 |
| KR20060066094A (ko) | 2006-06-15 |
| CN101935305B (zh) | 2013-04-10 |
| ES2383369T3 (es) | 2012-06-20 |
| MY154535A (en) | 2015-06-30 |
| KR20060066104A (ko) | 2006-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS2848B (is) | Súksínat- og malónatsalt af trans-4-(1R,3S)-6-klór-3-fenýlindan-1-ýl)-1,2,2-trímetýlpíperasíni og notkun sem lyf | |
| CY2013027I1 (el) | Νεα παραγωγα ινσουλινης | |
| PT1572707E (pt) | Novos derivados fluoroglicosideos aromaticos, farmacos contendo estes compostos e sua utilizacao | |
| DK1501815T3 (da) | Substituerede phenylacetamider og anvendelse deraf som glucokinaseaktivatorer | |
| NL1025404A1 (nl) | Pyrazolo-triazine verbindingen en gebruik daarvan. | |
| DK1480955T3 (da) | O-cyclopropyl-carboxanilider og deres anvendelse som fungicider | |
| DE60301088D1 (de) | Chirurgische Kassette | |
| NO20044322L (no) | Benzoksanon-avledede forbindelser, deres fremstilling og anvendelse som medikament | |
| DK1601363T3 (da) | Anvendelse som lægemiddel af derivater af cholest-4-en-3-on, farmaceutiske sammensætninger indeholdende disse og nye derivater | |
| DK1537096T3 (da) | Derivater af dioxan-2-alkylcarbamater, fremstilling og terapeutisk anvendelse heraf | |
| NO20053569L (no) | Substituerte 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazinderivater og deres anvendelse som nevrokininantagonister | |
| ATE432701T1 (de) | Indol-6-sulfonamid-derivate, ihre herstellung und ihre verwendung als 5-ht-6 modulatoren | |
| NO20054876D0 (no) | Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikament og medikament inneholdende slike forbindelser | |
| DK1516540T3 (da) | Anvendelse af vitamin D-forbindelser | |
| DE602004021384D1 (de) | Indol-5 -sulfonamid-derivate, ihre herstellung und verwendung als 5-ht-6 modulatoren | |
| BRPI0312413A2 (pt) | compostos, composições farmacêuticas contendo os mesmos, e método de utilização para os mesmos | |
| DK1658277T3 (da) | Succinat- og malonatsalt af trans-4-(1r,3s)-6-chlor-3-phenylindan-1-yl)-1,2,2-trimethylpiperazin og anvendelse som medikament | |
| DE602004013599D1 (de) | Herstellung von somatostatinpeptiden | |
| DK1492796T3 (da) | Substituerede aminoisoxazolinderivater og deres anvendelse som antidepressive midler | |
| NO20053910L (no) | Nye piperazinderivater og deres anvendelse som syntesemellomprodukter. | |
| NO20053598L (no) | Substituerte 1-piperidin-3-yl-4-pyrrolidin-4-yl-piperazinderivater og deres anvendelse som nevrokininantagonister. | |
| NO20054495D0 (no) | Nye anilinderivater, deres fremstilling og anvendelse som farmasoytiske forbindelser | |
| DE602004021383D1 (de) | Indol-7 -sulfonamid-derivate, ihre herstellung und verwendung als 5-ht-6 modulatoren | |
| DE602004016959D1 (de) | Kristallmodifikationen von triazinylaminostilbenen | |
| ATE359776T1 (de) | Kombination von arzneimitteln gegen diabetes |